Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew S P Sharp

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
JAMA Cardiology|February 28, 2023
Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO TrialsAjay J Kirtane, Andrew S P Sharp, Felix Mahfoud, et al.
Lancet (London, England)|May 28, 2018
Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trialMichel Azizi, Roland E Schmieder, Felix Mahfoud, et al.
JAMA|February 28, 2023
Endovascular Ultrasound Renal Denervation to Treat Hypertension: The RADIANCE II Randomized Clinical TrialMichel Azizi, Manish Saxena, Yale Wang, et al.
American Heart Journal|February 5, 2026
Reperfusion Strategies for Acute Pulmonary Embolism: Design and Rationale of RECONNECT-PE - a Living Systematic Review and Meta-analysisIoannis T Farmakis, Harald Binder, Romain Chopard, et al.
JACC. Cardiovascular Interventions|December 28, 2020
12-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Trial of Ultrasound Renal DenervationMichel Azizi, Joost Daemen, Melvin D Lobo, et al.
JACC. Cardiovascular Interventions|July 20, 2019
Algorithmic Versus Expert Human Interpretation of Instantaneous Wave-Free Ratio Coronary Pressure-Wire Pull Back DataChristopher M Cook, Takayuki Warisawa, James P Howard, et al.
International Journal of Cardiology|November 14, 2021
A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute STEMI patients undergoing primary PCIDavid Adlam, Maciej Zarebinski, Neal G Uren, et al.
Journal of the American College of Cardiology|November 1, 2023
Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive MedicationsDavid E Kandzari, Raymond R Townsend, Kazuomi Kario, et al.
Lancet (London, England)|May 19, 2021
Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trialMichel Azizi, Kintur Sanghvi, Manish Saxena, et al.
Circulation|May 24, 2018
Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Single-Vessel Coronary Artery DiseaseRasha Al-Lamee, James P Howard, Matthew J Shun-Shin, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
JAMA Cardiology|February 28, 2023
Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO TrialsAjay J Kirtane, Andrew S P Sharp, Felix Mahfoud, et al.
Lancet (London, England)|May 28, 2018
Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trialMichel Azizi, Roland E Schmieder, Felix Mahfoud, et al.
JAMA|February 28, 2023
Endovascular Ultrasound Renal Denervation to Treat Hypertension: The RADIANCE II Randomized Clinical TrialMichel Azizi, Manish Saxena, Yale Wang, et al.
American Heart Journal|February 5, 2026
Reperfusion Strategies for Acute Pulmonary Embolism: Design and Rationale of RECONNECT-PE - a Living Systematic Review and Meta-analysisIoannis T Farmakis, Harald Binder, Romain Chopard, et al.
JACC. Cardiovascular Interventions|December 28, 2020
12-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Trial of Ultrasound Renal DenervationMichel Azizi, Joost Daemen, Melvin D Lobo, et al.
JACC. Cardiovascular Interventions|July 20, 2019
Algorithmic Versus Expert Human Interpretation of Instantaneous Wave-Free Ratio Coronary Pressure-Wire Pull Back DataChristopher M Cook, Takayuki Warisawa, James P Howard, et al.
International Journal of Cardiology|November 14, 2021
A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute STEMI patients undergoing primary PCIDavid Adlam, Maciej Zarebinski, Neal G Uren, et al.
Journal of the American College of Cardiology|November 1, 2023
Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive MedicationsDavid E Kandzari, Raymond R Townsend, Kazuomi Kario, et al.
Lancet (London, England)|May 19, 2021
Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trialMichel Azizi, Kintur Sanghvi, Manish Saxena, et al.
Circulation|May 24, 2018
Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Single-Vessel Coronary Artery DiseaseRasha Al-Lamee, James P Howard, Matthew J Shun-Shin, et al.
Pageof 11